Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.950
+0.190 (6.88%)
At close: Mar 13, 2026, 4:00 PM EDT
2.920
-0.030 (-1.02%)
After-hours: Mar 13, 2026, 6:46 PM EDT

Processa Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6.311.194.716.516.515.42
Cash & Short-Term Investments
6.311.194.716.516.515.42
Cash Growth
118.17%-74.69%-27.64%-60.58%7.01%2129.27%
Other Receivables
-----0.15
Total Trade Receivables
-----0.15
Other Current Assets
0.280.690.931.881.830.63
Total Current Assets
6.591.885.638.3918.3316.2
Net Property, Plant & Equipment
00.080.150.230.070.16
Other Intangible Assets
--0.150.238.068.85
Other Long-Term Assets
0.991.270.010.010.010.01
Total Assets
7.583.235.798.6226.4625.21
Accounts Payable
0.730.880.310.330.220.32
Accrued Expenses
1.020.580.150.40.280.23
Current Portion of Long-Term Debt
-----0.12
Current Portion of Leases
-0.070.080.080.070.09
Other Current Liabilities
--0.190.190.40.47
Total Current Liabilities
1.751.530.7310.971.22
Long-Term Debt
-----0.04
Long-Term Leases
-00.070.150.010.08
Other Long-Term Liabilities
-----0.93
Total Long-Term Liabilities
-00.070.150.011.05
Total Liabilities
1.751.530.81.150.982.27
Common Stock
0.0100000
Treasury Stock
-0.3-0.3-0.3-0.3--
Additional Paid-in Capital
103.5589.2180.6672.0262.3148.33
Retained Earnings
-97.42-87.22-75.37-64.25-36.82-25.4
Shareholders' Equity
5.831.74.997.4725.4922.94
Total Liabilities & Equity
7.583.235.798.6226.4625.21
Total Debt
-0.070.150.230.080.33
Net Cash (Debt)
6.311.124.566.2716.4215.09
Net Cash Growth
464.35%-75.46%-27.39%-61.79%8.82%-
Net Cash Per Share
8.299.1386.84194.73535.891005.92
Book Value
5.831.74.997.4725.4922.94
Book Value Per Share
7.6613.8695.10231.87831.791529.36
Tangible Book Value
5.831.74.847.2417.4314.09
Tangible Book Value Per Share
7.6613.8692.21224.64568.83939.53
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q